Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated Sep 30, 2013 (13 years ago)

G & W Fluocinolone Acetonide Cream USP 0.025%

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed Content Uniformity Specifications; at the 18 month time point.

Cause type: Wrong potency / content

Sub- or super-potent product, or a failed content-uniformity / assay test. You may receive too little or too much active ingredient - a direct dosing risk. All wrong potency / content recalls.

What was recalled

G & W Fluocinolone Acetonide Cream USP 0.025%, a) 15 gm (NDC 0713-0222-15), b) 60 gm (NDC 0713-0222-60 ), Rx Only, Manufactured by: G&W Laboratories, Inc. 111 Coolidge Street, South Plainfield, NJ 07080

Affected NDCs 0713-0222-15 0713-0222-60

Compare with the code on your package — it is the most precise check available.

Drug: Fluocinolone

Recalling firm
G & W Laboratories Inc
NDC code
0713-0222-15
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-391-2014 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Fluocinolone recalls

See all
Class II · Moderate risk

Fluocinolone Acetonide Oil

Failed Excipient Specifications: OOS for assay of Isopropyl Alcohol

Terminated Failed specification Glenmark Pharmaceuticals Inc., USA NDC 68462-185-56 D-0259-2024
Class II · Moderate risk

DermOtic Oil

Presence of Foreign Substance: Potential for broken glass within the glass pipette of the dropper.

Terminated Particulate / foreign matter Hill Dermaceuticals, Inc. NDC 68791-103-20 D-0637-2021
Class II · Moderate risk

Formula 82M

Lack of Processing Controls (lack of assurance of conformity to specifications).

Terminated cGMP deviation MasterPharm LLC D-1424-2020
Class II · Moderate risk

Formula 82F

Lack of Processing Controls (lack of assurance of conformity to specifications).

Terminated cGMP deviation MasterPharm LLC D-1423-2020

Other recalls by G & W Laboratories Inc

All 2013 recalls
Class III · Low risk

Ciclopirox Olamine Cream USP

Discoloration: Product is supposed to be a white to off white homogenous cream and may have intermittent yellow discoloration.

Terminated Failed specification G & W Laboratories, Inc. NDC 0713-0638-15 D-0250-2018
Class III · Low risk

G & W Clobetasol Propionate Ointment 0.05%

Failed impurities/degradation specifications: This product is being recalled due to out of specification results for Clobetasol Related Compound A, a known impurity which is a degradation product.

Terminated Impurity / degradation G & W Laboratories, Inc. NDC 0713-0656-15 D-0945-2017
Class III · Low risk

Ciclopirox Olamine Cream USP

Labeling: Incorrect or Missing Package Insert: product lots packaged with an out-of-date insert.

Terminated Labeling / mix-up G & W Laboratories, Inc. NDC 0713-0638-15 D-0636-2017